Correlation Between Pharma Mar and Sacyr SA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharma Mar and Sacyr SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharma Mar and Sacyr SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharma Mar SA and Sacyr SA, you can compare the effects of market volatilities on Pharma Mar and Sacyr SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharma Mar with a short position of Sacyr SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharma Mar and Sacyr SA.

Diversification Opportunities for Pharma Mar and Sacyr SA

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pharma and Sacyr is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Pharma Mar SA and Sacyr SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sacyr SA and Pharma Mar is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharma Mar SA are associated (or correlated) with Sacyr SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sacyr SA has no effect on the direction of Pharma Mar i.e., Pharma Mar and Sacyr SA go up and down completely randomly.

Pair Corralation between Pharma Mar and Sacyr SA

Assuming the 90 days trading horizon Pharma Mar is expected to generate 2.05 times less return on investment than Sacyr SA. In addition to that, Pharma Mar is 3.06 times more volatile than Sacyr SA. It trades about 0.04 of its total potential returns per unit of risk. Sacyr SA is currently generating about 0.24 per unit of volatility. If you would invest  307.00  in Sacyr SA on April 22, 2025 and sell it today you would earn a total of  51.00  from holding Sacyr SA or generate 16.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pharma Mar SA  vs.  Sacyr SA

 Performance 
       Timeline  
Pharma Mar SA 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pharma Mar SA are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, Pharma Mar may actually be approaching a critical reversion point that can send shares even higher in August 2025.
Sacyr SA 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Sacyr SA are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Sacyr SA exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pharma Mar and Sacyr SA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharma Mar and Sacyr SA

The main advantage of trading using opposite Pharma Mar and Sacyr SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharma Mar position performs unexpectedly, Sacyr SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sacyr SA will offset losses from the drop in Sacyr SA's long position.
The idea behind Pharma Mar SA and Sacyr SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories